Befejeződött1. fázis
CA-4948-104: A Ph1 Study of Emavusertib in AML CR MRD+ Patients Currently Receiving Azacitidine and Venetoclax
Key facts
- Where
- Dresden, Hamburg, Jena és Leipzig, NémetországSee the 4 sites
- Phase
- 1. fázis
Where in Németország
- Technische Universität DresdenDresden, NémetországNo longer taking part
- University Medical Center Hamburg-EppendorfHamburg, NémetországNo longer taking part
- University Hospital Jena KöRJena, NémetországNo longer taking part
- Universitaet LeipzigLeipzig, NémetországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Curis Inc.
- Trial code
- EU 2023-505828-58-00
- Record updated
- 2026. május 19.